A provider of data management services for clinical trials has purchased CardioNow from Agfa Healthcare.
Agfa sells CardioNow
A provider of data management services for clinical trials has purchased CardioNow from Agfa Healthcare. With this acquisition, BioClinica plans to add within 45 days the ability to track, share, blindly interpret, and archive medical images for multi-center clinical trials to its services portfolio. Neither the price of the acquisition nor other details regarding the acquisition were publicly released. Executives at BioClinica expect to integrate CardioNow services into their portfolio, extending the company’s ability to manage the process that begins after a medical image is acquired as part of a clinical trial. Imaging information will also be integrated with BioClinica Express electronic data capture to simplify and enhance the clinical trial process for life science companies, according to BioClinica.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
MRI-Based AI Model Shows Promise in Predicting Lymph Node Metastasis with Breast Cancer
April 15th 2024For the prediction of axillary lymph node metastasis in patients with breast cancer, an MRI-based, 4D convolutional neural network model demonstrated an AUC of 87 percent and sensitivity of 89 percent, according to new research.